Serum amino acid concentrations were measured during the fasting and non-fasting stages of nutrition in three home parenteral nutrition patients who received their nitrogen requirement as Synthamin 17R for 12 months then Vamin N 7%R for 12 months. When the patients received Synthamin 17R, the fasting serum amino acid values revealed consistently elevated levels of glycine, phenylalanine, methionine and alanine and low levels of leucine, iso-leucine, valine, lysine, histidine, cystine and serine. When the patients received Vamin N 7%R, the fasting serum amino acid levels showed consistently elevated levels of proline, phenylalanine, glutamate, alanine, cystine and valine and low levels of arginine. Many of the serum amino acid abnormalities observed reflected the differences in the amino acid profiles of Vamin N 7%R and Synthamin 17 R when compared with a normal diet.
with them all. However, the ability of these solutions to maintain normal serum amino acid levels, particularly with prolonged intravenous administration, has received little attention.
In three patients who were managed at home and required prolonged administration of parenteral nutrition, serum amino acid estimations were performed when Synthamin 17R was used for twelve months and compared with the serum amino acid values when the equivalent amount of nitrogen was infused as Vamin N 71l7o R for a similar period.
PATIENTS AND METHODS
Three patients reqUIrIng prolonged parenteral nutrition were managed at home with intravenous nutrition being administered Anaesthesia and Intensive Care, Vol. 12 Intralipid 10%, 500-1000 ml was infused weekly to maintain the serum triene/tetrene ratio less than 0.2. The patient's clinical status, caloric intake and nitrogen intake are shown in Table 1 . The weight of all patients varied by less than 3% during the two-year period of the study. Serum samples for amino acid estimations were taken just before the infusion commenced (fasting) and just before the completion of the infusion (non-fasting). The amino acid concentrations were quantitated on a Beckman Multichrom B amino acid analyser using a modified Kedenberg 6 lithium buffer system, with Beckman M72 resin packed in a 50 cm x 0.9 cm column. Blood samples from 10 males and 10 females were used to derive normal fasting ranges of serum amino acid concentrations.
RESULTS
Serum amino acids were measured in all patients in both the fasted and non-fasted state at six months and twelve months after Synthamin 17R was used and again after Vamin N7%R was used. The results observed when assaying the fasting amino acid concentrations in 10 normal males and 10 normal females are expressed as a normal fasting range (mean and SO) ( Table 2) .
The graphs in Figures 1 and 2 show the individual serum amino acids as a percentage of normal. The shadowed area represents the normal range determined in 20 normal fasted males and females; 100% is the mean and for the purpose of aiding the graphic display, the Mean All patients were in either positive or zero nitrogen balance at the time of amino acid estimation.
When Synthamin 17R was infused elevated levels of phenylanine, methionine, alanine, aspartate, glutamate and glycine and low levels of leucine, iso-leucine, valine, lysine, histidine, cystine, serine and tyrosine were observed in the non-fasting state (Figure 1 ). In the fasted state the elevated serum amino acid level fell although pheynlalanine, methionine, alanine and glycine remained consistently above normal. Leucine, iso-leucine, valine, lysine, histidine, cystine and serine remained low and tyrosine rose to within low limits of normal (Figure 1) .
When the patients received Vamin N 70J0R, the measurements of serum amino acids in the non-fasted state revealed elevated levels of all amino acids measured other than tyrosine (Figure 2 ). In the fasted state, consistently high levels of phenylalanine, proline, glutamate, cystine and valine and low levels of arginine were observed (Figure 2 ). 
DISCUSSION
Measurements and interpretation of serum amino acid concentrations in reflecting the body's amino acid metabolism has been subject to much criticism. The values may not reflect the total body amino acid pooP or changes in the intracellular amino acid concentrations. 8 ,9 Arterio-venous differences due to skeletal muscle metabolism lO and RBC ll and WBC 12 transport of certain amino acids may also lead to inaccuracies when assessing amino acid metabolism by simply measuring their serum concentrations. However, measurements of serum amino acids can be performed accurately and under carefully controlled conditions studies of serum amino acid clearances have provided valuable information concerning amino acid metabolism l3 and requirements for normal human nutrition. 14 In patients who require long-term parenteral nutrition and who are otherwise normal, it would seem not unreasonable to believe that their fasting serum amino acids should be within the normal range, particularly since toxicity of elevated levels of certain amino acids l5 and malnutrition associated with consistently low levels of the branched chain amino acids has been reported. 16 Measuring the fasting serum amino acid concentrations in the three patients we observed, when using Synthamin 17R consistently elevated levels of methionine, phenylalanine, glycine and alanine and low levels of the branched chain amino acids (leucine, iso-leucine, valine) lysine, histidine, cystine and serine. Using Vamin N 7f1!0 we observed consistently elevated levels of phenylalanine, proline, glutamate, cystine and valine and low levels of arginine, although with only three patients statistical analysis could not be applied to the data. The amino acid composition of protein in 25 common foods 17 expressed as mmol of amino acids (mean and SD)/16 gm nitrogen (lOO gm protein equivalent) is shown in Figure 3 . In comparison, the amino acid formulation of Synthamin 17 R , when expressed in a similar fashion (Figure 4) , reveals lower or absent quantities of leucine, valine, cystine, serine and tyrosine, and larger amounts of glycine, methionine, phenylalanine and alanine. Vamin N 7% expressed in a similar fashion ( Figure 5 ) reveals a lower quantity of tyrosine and larger amounts of iso-leucine, valine, phenylalanine, methionine, threonine and serine. Some of these imbalances were reflected in the fasting serum amino acid concentrations measured in our patients and thus may simply indicate the difference in daily amino acid administration when compared with a normal diet. While we could not detect any clinical manifestations associated with the abnormalities observed in the serum amino acid concentrations, there would seem to be no advantage in infusing an amino acid solution which produces sustained abnormality in the serum amino acid concentrations. We have previously reported the correction of low serum levels of leucine, iso-leucine, valine, lysine and histidine in patients receiving Synthamin 17R by the addition of these amino acids. IS Synthamin 17R has not been reformulated # (Figure 6 ) and may reduce the abnormalities observed in the serum amino acids in long-term parenteral nutrition patients. Nevertheless, we believe that the formulations of all currently available intravenous amino acid solutions should be studied not only with regard to their ability to provide a positive nitrogen balance and enhance protein synthesis but also with regard to the extent and nature of the imbalances they impose upon the fasting serum amino acid profile.
